The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee
Immunity to solid tumors is associated with the hallmarks of cancer-associated inflammation and the ability of immune mechanisms to limit tumor progression. Application of expanded tumor-infiltrating lymphocyte adoptive T cell therapy (TIL ACT) in clinical trials is now practiced at many sites aroun...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
2025-11-01
|
| Edice: | Journal for ImmunoTherapy of Cancer |
| On-line přístup: | https://jitc.bmj.com/content/13/11/e013420.full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
